CRISPR Therapeutics AG
NASDAQ: CRSP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Samarth Kulkarni
- Employees
- 393
- Headquarters
- Zug, Switzerland
- IPO year
- 2016
- Market cap
- $5.2B
- Website
- https://www.crisprtx.com
Loading CRSP…
Loading profile data…Frequently asked questions about CRSP
What does CRISPR Therapeutics AG (CRSP) do?
CRISPR Therapeutics AG (CRSP) is a biotechnology firm dedicated to pioneering gene-based medicines for severe diseases. The company achieves this through its exclusive Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) technology, which enables precise and targeted alterations to an organism's g...
Where does CRSP trade?
CRISPR Therapeutics AG (CRSP) trades on the NASDAQ Global Market.
What sector is CRSP in?
CRISPR Therapeutics AG (CRSP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of CRISPR Therapeutics AG?
Samarth Kulkarni is the chief executive officer of CRISPR Therapeutics AG (CRSP).
Where is CRISPR Therapeutics AG headquartered?
CRISPR Therapeutics AG is headquartered in Switzerland.
Does CRSP pay a dividend?
CRISPR Therapeutics AG (CRSP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CRSP go public?
CRISPR Therapeutics AG (CRSP) completed its initial public offering in 2016.